Common Contracts

37 similar null contracts by Aridis Pharmaceuticals, Inc., Bit Brother LTD, Golden Matrix Group, Inc., others

Bit Brother Limited (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt Securities
Bit Brother LTD • January 16th, 2024 • Retail-eating places • New York

INDENTURE, dated as of [●], 20[●], among Bit Brother Limited, a British Virgin Islands company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).

AutoNDA by SimpleDocs
BAOSHENG MEDIA GROUP HOLDINGS LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt Securities
Baosheng Media Group Holdings LTD • August 4th, 2023 • Services-business services, nec • New York

INDENTURE, dated as of [●], 20[●], among Baosheng Media Group Holdings Limited, a Cayman Islands exempted company with limited liability (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).

INDENTURE INDENTURE, dated as of [●], 20[●], between Bird Global, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”): WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and...
Bird Global, Inc. • June 23rd, 2023 • Motorcycles, bicycles & parts • New York
HOTH THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES
Hoth Therapeutics, Inc. • June 13th, 2023 • Pharmaceutical preparations • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

CYTOKINETICS, INCORPORATED AND _____________, AS TRUSTEE FORM OF INDENTURE DATED AS OF __________ Debt Securities
Cytokinetics Inc • November 18th, 2022 • Pharmaceutical preparations • New York

THIS INDENTURE, dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

POP CULTURE GROUP CO., LTD (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt Securities
Pop Culture Group Co., LTD • July 14th, 2022 • Services-amusement & recreation services • New York

INDENTURE, dated as of [●], 20[●], among Pop Culture Group Co., Ltd, a Cayman Islands company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).

GOLDEN MATRIX GROUP, INC., Issuer AND Trustee INDENTURE Dated as of [●], 20[●] Debt Securities INDENTURE
Golden Matrix Group, Inc. • April 22nd, 2022 • Services-prepackaged software • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

FLUSHING FINANCIAL CORPORATION, AS ISSUER AND WILMINGTON TRUST, NATIONAL ASSOCIATION, AS TRUSTEE SUBORDINATED INDENTURE DATED AS OF NOVEMBER 22, 2021 SUBORDINATED DEBT SECURITIES CROSS-REFERENCE TABLE
Flushing Financial Corp • November 22nd, 2021 • State commercial banks • New York

THIS INDENTURE, dated as of November 22, 2021 between Flushing Financial Corporation, a corporation duly organized and existing under the laws of the State of Delaware (the “Company”), and Wilmington Trust, National Association, as trustee (the “Trustee,” which term shall include any successor trustee appointed pursuant to Article 7 of this Indenture).

GOLDEN MATRIX GROUP, INC., Issuer AND Trustee INDENTURE Dated as of [●], 20[●] Debt Securities INDENTURE
Golden Matrix Group, Inc. • October 5th, 2021 • Metal mining • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

ELYS GAME TECHNOLOGY, CORP. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt Securities
Elys Game Technology, Corp. • June 4th, 2021 • Services-prepackaged software • New York

Indenture, dated as of __________________, 20__, among Elys Game Technology, Corp., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

Bit Brother Limited (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [·], 20[·] Senior Debt Securities
Bit Brother LTD • May 28th, 2021 • Retail-eating places • New York

INDENTURE, dated as of [●], 20[●], among Bit Brother Limited, a British Virgin Islands company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).

SUMMIT FINANCIAL GROUP, INC. AS ISSUER, AND AS TRUSTEE, SENIOR INDENTURE DATED AS OF [________________, _______] SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE
Summit Financial Group, Inc. • May 3rd, 2021 • State commercial banks • New York

Reconciliation and tie between the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”), and the Indenture dated as of __________, 2021.

GREEN PLAINS INC. Issuer AND WILMINGTON TRUST, NATIONAL ASSOCIATION Trustee INDENTURE Dated as of March 1, 2021
Green Plains Inc. • March 1st, 2021 • Industrial organic chemicals • New York
HAPPINESS BIOTECH GROUP LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt Securities
Happiness Biotech Group LTD • November 12th, 2020 • Medicinal chemicals & botanical products • New York

INDENTURE, dated as of [●], 20[●], among Happiness Biotech Group Limited, a Cayman Islands corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).

HOTH THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES
Hoth Therapeutics, Inc. • March 4th, 2020 • Pharmaceutical preparations • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

TRISTATE CAPITAL HOLDINGS, INC., AS ISSUER, AND AS TRUSTEE, SENIOR INDENTURE DATED AS OF [________________, _______] SENIOR DEBT SECURITIES
TriState Capital Holdings, Inc. • December 26th, 2019 • State commercial banks • New York

THIS INDENTURE, dated as of [_____________,______], between TriState Capital Holdings, Inc., a corporation duly organized and existing under the laws of the State of Pennsylvania (the “Company”), and [________________], as trustee (the “Trustee,” which term shall include any successor trustee appointed pursuant to Article 7 of this Indenture).

ORIGIN BANCORP, INC., AS ISSUER, AND AS TRUSTEE, SENIOR INDENTURE DATED AS OF [________________, _______] SENIOR DEBT SECURITIES
Origin Bancorp, Inc. • October 3rd, 2019 • State commercial banks • New York

THIS INDENTURE, dated as of [_____________,______], between Origin Bancorp, Inc., a corporation duly organized and existing under the laws of the State of Louisiana (the “Company”), and [________________], as trustee (the “Trustee,” which term shall include any successor trustee appointed pursuant to Article 7 of this Indenture).

CHINA INTERNET NATIONWIDE FINANCIAL SERVICES INC. Issuer AND [Trustee], Trustee INDENTURE Dated as of [●], 20[●] Senior Debt Indenture
China Internet Nationwide Financial Services, Inc. • September 11th, 2019 • Services-management consulting services • New York

Indenture, dated as of [●], 20[●], among China Internet Nationwide Financial Services Inc., a British Virgin Islands exempted company (the “Company”), and [Trustee], as trustee (the “Trustee”):

ARIDIS PHARMACEUTICALS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES
Aridis Pharmaceuticals, Inc. • September 3rd, 2019 • Pharmaceutical preparations • New York

INDENTURE , dated as of [ · ], among Aridis Pharmaceuticals, Inc. , a Delaware corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):

ARIDIS PHARMACEUTICALS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES
Aridis Pharmaceuticals, Inc. • August 13th, 2019 • Pharmaceutical preparations • New York

INDENTURE , dated as of [ · ], among Aridis Pharmaceuticals, Inc. , a Delaware corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):

RASNA THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES
Rasna Therapeutics Inc. • April 6th, 2018 • Pharmaceutical preparations • New York
RASNA THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES
Rasna Therapeutics Inc. • April 6th, 2018 • Pharmaceutical preparations • New York

INDENTURE, dated as of [ · ], among Rasna Therapeutics, Inc., a Nevada corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

AutoNDA by SimpleDocs
SYNERGY PHARMACEUTICALS INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES
Synergy Pharmaceuticals, Inc. • November 13th, 2017 • Pharmaceutical preparations • New York

INDENTURE , dated as of [ · ], among Synergy Pharmaceuticals Inc. , a Delaware corporation (the “Company”), and [ T RUSTEE ], as trustee (the “Trustee”):

Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 7.09 310(b) 7.08 7.10 310(c) Inapplicable 311(a) 7.13 311(b) 7.13 311(c) Inapplicable 312(a) 5.01 5.02(a) 312(b) 5.02(c) 5.02(d) 312(c) 5.02(e) 313(a) 5.04(a) 313(b)...
AEP Transmission Company, LLC • April 5th, 2017

THIS INDENTURE, dated as of the 1st day of November, 2016, between AEP TRANSMISSION COMPANY, LLC, a limited liability company duly organized and existing under the laws of the State of Delaware (hereinafter sometimes referred to as the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association organized under the laws of the United States, as trustee (hereinafter sometimes referred to as the “Trustee”):

BIOPTIX, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES
Bioptix, Inc. • February 8th, 2017 • In vitro & in vivo diagnostic substances • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the "Securities"), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

S&W Seed Company, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 201__ Debt Securities
S&W Seed Co • December 2nd, 2016 • Agricultural production-crops • New York

Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the "Securities"), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

Protalix BioTherapeutics, Inc., Issuer AND Trustee INDENTURE Dated as of _____ ___, 201_ CROSS-REFERENCE TABLE*
Protalix BioTherapeutics, Inc. • November 27th, 2015 • Biological products, (no disgnostic substances) • New York

*This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.

BIOCEPT, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of _______, 20__ Debt Securities
Biocept Inc • May 13th, 2015 • Services-medical laboratories • New York

Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

SEQUENOM, INC. ISSUER AND [TRUSTEE], TRUSTEE FORM OF SENIOR DEBT INDENTURE
Sequenom Inc • November 23rd, 2011 • Measuring & controlling devices, nec • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of senior debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

SUBORDINATED INDENTURE VERTEX PHARMACEUTICALS INCORPORATED, ISSUER AND U.S. BANK NATIONAL ASSOCIATION, TRUSTEE INDENTURE Dated as of September 28, 2010 Subordinated Debt Securities
Vertex Pharmaceuticals Inc / Ma • September 29th, 2010 • Pharmaceutical preparations • New York

INDENTURE, dated as of September 28, 2010, between VERTEX PHARMACEUTICALS INCORPORATED, a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts, having its principal office at 130 Waverly Street, Cambridge, Massachusetts 02139 (the “Company”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”):

SEQUENOM, INC. ISSUER AND [TRUSTEE], TRUSTEE FORM OF SENIOR DEBT INDENTURE
Sequenom Inc • September 21st, 2010 • Measuring & controlling devices, nec • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of senior debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

ANADYS PHARMCEUTICALS, INC., Issuer AND U.S. BANK NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of March 24, 2006 Senior Debt Securities
Anadys Pharmaceuticals Inc • March 27th, 2006 • Pharmaceutical preparations • New York

Indenture, dated as of March 24, 2006, among Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”):

SENOMYX, INC., Issuer AND U.S. BANK NATIONAL ASSOCIATION, Trustee
Senomyx Inc • October 6th, 2005 • Services-commercial physical & biological research • New York

INDENTURE, dated as of October 6, 2005, among SENOMYX, INC., a Delaware corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”):

NEKTAR THERAPEUTICS, Issuer AND J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, Trustee
Nektar Therapeutics • October 27th, 2004 • Pharmaceutical preparations • New York

INDENTURE, dated as of [ • ], among NEKTAR THERAPEUTICS, a Delaware corporation (the "Company"), and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, as trustee (the "Trustee"):

NEKTAR THERAPEUTICS, Issuer AND J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, Trustee
Nektar Therapeutics • October 27th, 2004 • Pharmaceutical preparations • New York

INDENTURE, dated as of [ • ], among NEKTAR THERAPEUTICS, a Delaware corporation (the "Company"), and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, as trustee (the "Trustee"):

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!